Tocilizumab in Patients With Polymyalgia Rheumatica Receiving Glucocorticoid Therapy

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=cq_F7sLqtuE

JAMA Deputy Editor Mary McDermott, MD, gives editorial insight into a randomized clinical trial comparing the efficacy of tocilizumab vs placebo in patients with glucocorticoid-dependent polymyalgia rheumatica, published in the September 20, 2022, issue of JAMA. For full details, click https://ja.ma/3f4GiDD and visit https://jamanetworkvideo.com/ for more content like this. • Topics discussed in this interview: • 00:00 Introduction • 00:57 Tocilizumab • 01:23 SEMAPHORE Randomized Clinical Trial • 01:58 Intervention and Results • 03:14 Trial Interpretation and Importance • --------------------------------------------------------------------------------- • For more from JAMA • • https://www.jama.com • • / jamajournal • • / jama_current • • / jama. . • Follow the JAMA Network • • https://www.jamanetwork.com • • http://www.jamanetworkaudio.com • • / jamanetwork • • / jamanetwork • • / jamanetwork • • / jamanetwork

#############################

New on site